Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Receivables of $1.62 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $11,948 a year earlier and down 32.7% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Receivables for 13 quarters.
- Annual Receivables shows a five-year compound annual growth rate of 0.5% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Receivables was $11,948 in FY2025 (-94.6%), $223,038 in FY2024 (-73.7%), $848,708 in FY2023 (-91.2%) and $9.67 million in FY2022 (+510.8%).
- Quarterly Receivables has run from a low of $1,758 in fiscal Q1 2026 to a high of $4.86 million in fiscal Q4 2022 over five years.
- According to Business Quant data, Receivables for the three prior fiscal quarters was $2.41 million (Q3 2026), $1.6 million (Q2 2026) and $1,758 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - | 1.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1,758.00 |
| Jun 30, 2025 | 11,948.00 |
| Mar 31, 2025 | 24,592.00 |
| Dec 31, 2024 | 35,561.00 |
| Sep 30, 2024 | 216,585.00 |
| Jun 30, 2024 | 223,038.00 |
| Dec 31, 2023 | 621,029.00 |
| Jun 30, 2023 | 425,168.81 |
| Dec 31, 2022 | 6.76 Mn |
| Jun 30, 2022 | 4.67 Mn |
| Dec 31, 2021 | 813,377.01 |
| Jun 30, 2021 | 847,748.22 |
| Jun 30, 2020 | 1.25 Mn |
API Access
Neuphoria Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();